|
|
Volumn 31, Issue 2, 2013, Pages 100-103
|
|
Fresh from the biotech pipeline-2012
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
ANTINEOPLASTIC AGENT;
BIOSIMILAR AGENT;
CARBOXYPEPTIDASE G2;
DUCORD;
FLUCELVAX;
GATTEX;
GINTUIT;
GLUCAGON LIKE PEPTIDE 2;
INFLUENZA VACCINE;
IVACAFTOR;
LINACLOTIDE;
LUCINACTANT;
OCRIPLASMIN;
ORPHAN DRUG;
PASIREOTIDE;
PEGINESATIDE;
PERTUZUMAB;
PROTALIX;
RAXIBACUMAB;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TALIGLUCERASE ALFA;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIVIRAL THERAPY;
ARTICLE;
BIOTECHNOLOGY;
CELL THERAPY;
CYSTIC FIBROSIS;
DRUG APPROVAL;
DRUG CLEARANCE;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 1;
LICENCE;
NONHUMAN;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROTEIN BINDING;
TREATMENT INDICATION;
DRUG APPROVAL;
HUMANS;
TISSUE THERAPY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84873592913
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2498 Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
